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One could argue that balneotherapy and mud therapy would have not lasted 2,000 years or so if they
were not effective. No doubt a long history cannot be taken per se as scientific proof of efficacy. Some
empiricism is still present in the field: the concept of spa itself is quite confounding, whereas spring
waters are used for leisure purposes but also for non-acute patient therapy and late phases of clinical
recovery. These confounding elements ultimately feed the opinion of those who aprioristically reject any
potential beneficial effect of balneotherapy: instead, it should at least generate questions that deserve
scientific answers. Clinical practices sequentially integrating pharmacological therapy with those natural
principles for which a sufficient scientific demonstration is available, would probably cut the costs of
public health, generating widespread advantages for the community. Recently, it has become evident
that mineral waters may have intrinsic pharmacological properties. Of the numerous salts dissolved in
thermal waters that might show pharmacological properties, for certain hydrogen sulfide (HzS)contained
in sulfurous waters is the one that has obtained greater scientific attention, to which should be added
the extensive scientific effort recently dedicated to HzSas a cellular gasotransmitter, independently from
its natural sources. Dermatology and cosmetics are among the most studied applications of sulfurous
waters, around which, however, some empiricism still confounds opinions: we therefore considered that
a state-of-the-art focus on this topic might be timely and useful for future studies.
Hydrogen sulfide is a gaseous transmitter
HzS - generally known as the malodorous rotten
eggs smelly gas - belongs to the gaseous transmitter
family together with nitric oxide (NO) and carbon
monoxide (CO) (1) and has recently generated
great scientific interest for its ability to resuscitate
small animals (2). Although still far from the more
famous NO and CO "cousins", that from 2007 to
2012 have been addressed in approximately 840,000
and 240,000 papers respectively, HzS has been cited
"only" 41,000 times (in nearly 6,100 papers) in the
medical and biological scientific community in the
same period [from lSI Web of Knowledge, Thomson
Reuters].
The first evidence of biological activity of HzS
was reported for the liver and kidney, where the HzS-
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Table I. Effects ofH2S.
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activity
Proliferation
cell death
IL-2 secretion
proliferation, adhesion
cell death
CoCl2 hypoxic stress
IL- I~, IL-6, IL-8, VEGF secretion
IL- I7 and IL-22-mediated activation
LPS-induced activation
IL-6 secretion
activity
dandruff, scaling, dryness
pruritus
fungal, bacterial and parasite growth
radiation exposure side effects
would healing
acanthosis, hyperkeratosis
vessel dilation
ERK activation and IL- secretion
target
T cells (CD8, CD4, NK, Thl)
T cells (CD8, CD4, NK)
T cells (CD8 and CD4)
keratinocytes
keratinocytes
keratinocytes
keratinocytes
keratinocytes
macrophages, endothelial cells
fibroblasts
target
skin
skin
skin
skin
skin
skin
derma
epidermis
generating enzymes were studied in detail starting 30
years ago (I). Since then it has become evident that
H2S plays several other biological roles and functions
involving neurological, cardiovascular, inflammatory
and cancer diseases, which is no surprise, as H2S is
endogenously produced in most cells. Endogenous
H2S production is dependent on the complex of
catabolic pathways of the sulfured amino acids
and of glutathione reduction (GSH), and is strictly
related to the control of the redox state of the cell.
In particular, HoS is made by pyridoxal-phosphate-
dependent enzymes, including cystathionine-c-lyase
(CGL, CSE), cystathionine-B-synthase (CBS) and
3-mercaptopyruvate sulfurtransferase (3-MST),
during cysteine metabolism (1, 3). The putative
quantification of the exact free and bioavailable
sulfide levels in blood and tissues is probably from
50 to 150 11M; however, substantial differences in
the absolute values have been reported. There are
relevant differences in the methods and protocols
used to quantify sulfuric acid and, in general, a
number of sulfurous molecules acting as H2S donors
have been described (3).
The anti-inflammatory properties of H2S-rich
waters on the skin have been known for centuries
(4), however, its molecular mechanisms are just
starting to be understood, with growing attention to
keratinocytes. The specific interest for skin derives
from its potentially simple translation to patient
care. This review focuses on the role of H2S on
skin in general and keratinocytes in particular, as a
framework for the topical complementary treatment
of specific skin diseases with H2S/sulfurous waters.
Sulfurs in skin therapy
Most of the scientific literature on H2S effects
on cell viability, proliferation, activation, cytokine
secretion and adhesion, refers to macrophages,
granulocytes, fibroblasts, smooth muscle cells,
myoblasts, cardiomyocytes, neuroblastoma cells,
neurons, astrocytes, hepatocytes, endothelial cells,
lymphocytes, intestinal epithelial and colon cancer
cells (3). As far as skin is concerned, sulfurs are able
to penetrate the skin and a sulfur-rich balneotherapy,
known to be effective in the treatment of psoriasis
(5), may be useful also in other T-cell-mediated
autoimmune diseases of the skin.
Sulfur has a long history of topical use: hydrogen
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Fig. 1. H:S signaling on keratinocyte and lymphocyte activation, proliferation and inflammatory cytokine secretion in
autoimmune skin diseases. Macrophages (Ma), T lymphocytes (CD8+. CD4+ and CD4 Thl7 subset), natural killer (NK)
and keratinocytes ofdermis and epidermis layers are shown. Stimulation and inhibition signaling pathways are indicated
by an arrow and by a black line (flat head), respectively.
sulfide is present in a variety of skin care products,
including soaps and cleansers (6), and is used to reduce
dandruff and decrease scalp scaling and dryness (7). It
has recognized fungicidal, bactericidal and antipruritic
properties, and therefore it is used for the therapy of
mite infestations in animals. Sulfur was even proposed
as an antidote for acute exposure to radioactive material
(8). Indeed, it has been demonstrated that sulfurs favor
wound healing, acts as a keratolytic agent and can
induce various histological modifications in the skin
(including hyperkeratosis, acanthosis, and dilation of
dermal vessels).
Cytokines in skin inflammatory diseases
Psoriasis is now considered a genetically
programmed, immune-mediated, skin-specific
inflammatory disease, in which intralesional T
lymphocytes trigger keratinocytes to proliferate and
perpetuate the disease process (9). Epidermal T cells
are mainly CD8+, whereas dermal T lymphocytes
are a mixture of CD4~ and CD8~ cells, with a CD4~
predominance ( I0, II). Recent studies on the cellular
pathogenesis of psoriasis revealed the involvement
of specific classes of CD4+ T lymphocytes. In
particular, it has been demonstrated that the Th 17/
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Th 1 and Th 17/Treg ratios strongly change in
psoriasis, with a predominant accumulation ofThl7
cells and reduction ofTreg.
In psoriatic plaque, the presence of Th l-type
cytokines, including interferon (INF)-g, interlukin
(IL)-2 and tumour necrosis factor (TNF)-a has been
demonstrated (9). Relevant cytokines produced by
the keratinocytes of psoriatic lesions, such as IL-6
and IL-8, have been shown to induce keratinocyte
proliferation (11). The more recently described IL-
15, IL-17, IL-19, IL-20, IL-22 and IL-23, that also are
found in psoriatic lesions and which also influence
keratinocyte proliferation, are mainly produced by
cells of hematopoietic origin such as dendritic (DC),
macrophages, lymphocytes and granulocytes (12).
Studies on the role of interleukins secreted by Thl7
cells (IL-17 and IL-22) revealed a complex interaction
between T cells and keratinocytes (11, 12) in several
inflammatory skin pathologies including acanthosis,
atopic dermatitis, cutaneous lupus erythematosus
(13). Increased IL-17 and IL-22 expression levels
have been found in psoriatic lesions and epidermal
hyperplasia (14, 15); both IL-17 and IL-22 have
been shown to induce keratinocyte gene expression
of antimicrobial ~-defensins S100A8 and S I00A9,
all up-regulated in psoriatic lesions (11, 15). IL-8
released by keratinocytes has been shown to be
induced by IL-17 via extracellular-signal-regulated
kinase (ERK) activation (11, 16, 17). Released
IL-8, vascular endothelial growth factor (VEGF),
and TNF-u promote neoangiogenesis, neutrophil
and lymphocyte extravasation, perpetuating skin
inflammation and dermal infiltration ofinflammatory
cells.
Another relevant pathogenic factor that must
be considered in skin inflammatory pathologies
is hypoxia, which impairs would healing and
mediates dermic injury in various diseases, such
as pressure, diabetic and venous ulcers (18).
Hypoxia mediates dermic injury by promoting the
expression of important pro-inflammatory mediators
as prostaglandins, that are synthesized through the
activation of keratinocyte cyclooxygenases (19).
In summary, a rationale therapeutic approach
to inflammatory skin pathologies should limit
activation, cytokine secretion and proliferation of
keratinocytes and immune cells, in particular CD4+
and CD8+lymphocytes.
H2S and inflammation
It is now becoming evident that HzS exerts non-
univocal effects on inflammation. For example, it
has been reported that administration of NaHS, a
fast releasing HzS donor, induces an inflammatory
reaction in liver and lung, and the extravasation of
leukocytes in the lung (3).
On the contrary, several data support anti-
inflammatory effects of sulfurs: their ability to
inhibit leukocyte adhesion to gastric mucosal
blood vessels (3); their scavenger activity for pro-
inflammatory oxidants (3, 20); their attenuation
of lipopolysaccharide-induced formation of
inflammatory mediators in macrophages (21); their
inhibition of IL-6 secretion from fibroblasts in the
synovial membrane of rheumatoid arthritis patients
(22).
Sulfurous spa waters are known for their anti-
inflammatory properties. Different waters (most of
which contain sulfurs in various combinations with
halogens or other ions) exert known beneficial effects
on mucosal surfaces ofthe upper respiratory airways,
and are normally administered by inhalation or
aerosol (4, 23, 24), restoring mucociliary clearance,
physiological drainage and micro-environment of
the upper airways and the Eustachian tubae (4). The
molecular pathways underlying the role of hydrogen
sulfide in inflammatory processes have therefore
been a research challenge for balneotherapy for
many years. It has been known for more than two
decades that sulfur thermal waters have inhibitory
effects on the proliferative response of T cells (25).
In a pioneering study, Valitutti et al. analyzed in
vitro the phenotype and proliferation of peripheral
blood mononuclear cells (PBMC) from ten patients
treated with a 14-day cycle of inhalatory therapy for
upper respiratory disorders and six patients taking
mud therapy for osteoarticular diseases. Although
inhalatory or mud therapy did not induce alterations
in lymphoid subset distribution (as defined by CD2,
CD3, CD4, CD8, CDl9 surface antigen expression),
PBMC were highly sensitive to sulfur-enriched
water in in vitro assays. The anti-proliferative effects
of sulfurs were dose-dependent and more evident on
anti-CD3, rather than PHA, stimulation. Moreover,
Valitutti and coworkers hypothesized that the
inhibitory effects of low dose sulfurs on lymphocyte
proliferation was Thl-memory-restricted because
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exogenous IL-2 and/or INF-y were able to revert
it. Much more recently, we studied the effects of
hydrogen sulfide on human lymphocyte subset
viability, proliferation and cytokine secretion (26).
Hydrogen sulfide induced a caspase-independent cell
death ofhuman lymphocytes, with differential effects
among lymphocyte subsets: CD8+ T lymphocytes
and NK cells were far more sensitive to the toxic
effects of sulfides than CD4+T cells. However, while
high doses ofNaHS (2 mM) killed more than 80% of
T cells, a residual significant fraction (50%) of NK
still survived. Both surviving CD4 and CD8 T cells
showed a decreased proliferative capacity in response
to PHA and IL-2. Moreover, NaHS-surviving NK
cells showed a decreased spontaneous cytotoxicity
against tumor target cells and neither CD8 nor CD4
T cells secreted significant levels of IL-2 during
activation. As previously reported, monocytes were
resistant to sulfurs (26) while caspase-dependent
neutrophil cell death is delayed by NaHS via p38
activation (27).
H2S and the cytokine secretion ofkeratinocytes
The exact role of H2S in inflammation is
controversial since both pro- and anti-inflammatory
effects have been documented. However, the role of
sulfurs on keratinocyte activation and inflammatory
cytokine secretion is emerging. Recently, it
was reported that hydrogen sulfide can protect
keratinocytes against chemical hypoxia-induced
inflammatory response. Cobalt chloride (CoCI2) ,
a well-known mimetic agent of hypoxia/ischemia,
induces oxidative stress and inflammation. NaHS
inhibits the inflammatory response of keratinocytes
to cobalt chloride exposure. In particular, it has been
demonstrated that NaHS significantly attenuates
CoCl2-stimulated interleukin IL-6, IL-8 and IL-l p
secretions from human keratinocyte-derived HaCaT
cells (28). Yang et al. speculated that NaHS could act
by promoting elimination of ROS produced during
hypoxia. Although a definitive in vivo demonstration
is lacking, it has been shown that NaHS is able to
eliminate superoxide anions and HP2 both by
direct interaction (3) and, indirectly, via the potent
endogenous antioxidant scavenger GSH (1, 3). The
anti-inflammatory signaling of sulfuric acid on skin
can be also obtained by the inhibition of cytokine
secretion by other cell types (such as macrophages,
fibroblasts, endothelial cells), that playa role in the
architectural changes of skin structure in psoriasis
and other immune-based diseases. In particular, H2S
has been shown to attenuate lipopolysaccharide-
induced formation of inflammatory mediators in
macrophages and vascular endothelial cells (21) and,
in addition, it also inhibits IL-6 secretion from the
fibroblasts of the synovial membrane in rheumatoid
arthritis patients (22). Cytokines highly expressed by
keratinocytes ofpsoriatic skin, such as IL-6 and IL-8,
have been shown to induce keratinocyte proliferation
and promote the recruitment of both neutrophils
and T lymphocytes, thus greatly contributing to
the pathophysiology of psoriasis (11). Recently,
we have demonstrated both in vitro and in vivo that
hydrogen sulfide not only reduces basal expression
and secretion of IL-8, but also interferes with IL-17
and IL-22-induced IL-8 production by impairing
ERK phosphorylation levels (11).
As far as the mechanism by which NaHS may
impair ERK phosphorylation on keratinocytes,
we observed that (29) hydrogen sulfide rapidly
down-regulates phospho-ERKs levels by blocking
MAPK kinases (MEK)-1I2 activation. Moving
upstream along the MAPK signalling axis, we also
demonstrated that NaHS signalling converges to
serine/threonine protein phosphatases-l and 2A, that
are known to activate the Raf/MEK/ERK pathway by
inducing the dephosphorylation of Raf-l at ser 259
(an inhibitory phosphorylation site). Very recently,
Merighi et al. reported that sulfurs may reduce
VEGF secretion of human skin-derived keratinocyte
cell lines (NCTC). The mechanism by which NaHS
impairs VEGF transcription and protein secretion
involves NO production (30). In particular, these
Authors demonstrated that NaHS, by activating
the classical membrane phospholipid breakdown
singaIling pathway, generated an Akt-dependent
induction of inducible nitric oxide synthase (iNOS)
expression followed by NO production. These
increased levels ofNO, in tum, reduced the activation
levels of the MAPK signaling pathway, preventing
VEGF transcription in an ERK-II2-dependent way.
H2S and keratinocyte growth
Human and mouse keratinocytes express a6p4
(laminin-5 receptor) integrin that contributes to their
anchorage to the basal membrane in situ. Moreover,
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demonstrated the
H2S at micromolar
a6p4 promotes keratinocyte migration and activates
signaling pathways that are synergistic with those of
growth factor receptors (31). More in general, a6p4
is necessary for tumor cell invasion, cooperates with
c-met in the transformation of rodent fibroblasts and
is necessary to maintain the tumorigenic phenotype
of carcinoma cells. Recently, we demonstrated that
NaHS is able to inhibit the expression of a6p4 in
keratinocytes and can be considered relevant in the
control ofkeratinocyte growth and adhesion. In fact,
NaHS-induced reduction of p4-integrin expression
in the NCTC cell line can explain sulfur-induced
cell death as well as sulfur-mediated inhibition of
keratinocyte clonal growth and cell adhesion (29).
The NaHS-mediated interference with the Ras/ ERK-
1/2 kinase, with the consequent down-regulation of
ERKs phosporylation observed after sulfur treatment
is responsible for a6p4 inhibition.
According to previous studies, keratinocytes
of hyperplastic epidermis express high levels of
pERK with the classical nuclear localization, while
keratinocytes of normal skin show low pERK levels
with a main cytoplasmic localization. By in vivo
experiments, we have shown that topic treatment of
psoriatic lesions with NaHS water solutions at sulfur
concentrations simi lar to that used for balneotherapy,
was sufficient to reduce ERK levels in intralesional
keratinocytes and, as expected, to reduce their IL-8
production, as well (II, 29).
Purified sulfur has been used as a therapeutic
agent to relieve the side effects of radiation therapy
in the treatment of cervical cancer. The effects
of sulfur on cell proliferation, cell division, and
apoptosis in immortalized human skin and oral
keratinocytes (HaCaT and IHOKs) and in two oral
SCC cell lines (HN4, HNI2) was studied (32). H2S
induced the morphological and biochemical changes
characteristic of apoptosis, as indicated by sub-G I
phase accumulation, increase in annexint/Pl" cells,
chromatin condensation and DNA fragmentation.
The down-regulation of BcI-2, cyclins 0 I, 02, and
E, and the up-regulation of p53, CDK inhibitor p21,
and p 16 have been proposed as the most relevant
molecular mechanism of hydrogen sulfide-mediated
anti-proliferative effects (32). However, several
studies have recognized H2S as a rescuer from
hypoxia-induced cell damage (I, 3, 33, 34), and a
similar anti-apoptotic activity may also take place on
keratinocytes (28).
It is remarkable that topical administration ofH2S
promotes dermal wound healing, whereas genetic
ablation of CSE attenuates it. Angiogenesis is
crucial in the early stages of wound healing and the
administration of H2S to endothelial cells in culture
stimulates cell proliferation, migration and tube
formation. Moreover, sulfurs stimulate blood vessel
growth and branching in vivo (35). Angiogenetic
mediators such as VEGF and angiopoietin-2 play
significant roles in the pathophysiology of psoriasis
and may even account for the maintenance ofchronic
inflammation: thus one could expect unfavorable
effects from the topical treatment ofpsoriatic lesions
with sulfurs or sulfur-rich waters due to its intrinsic
pro-angiogenic activity. We try a reconciliation of
this apparent paradox in the next paragraph.
Fast vs slow H2S releasing agents
One interesting property of fast H2S donors as
NaHS salts, is the low risk ofsevere secondary effects
due to accumulation in unrelated tissues and cells.
In fact, at physiological pH values, NaHS rapidly
dissociates in Na+ and HS- ions that are rapidly
converted into gaseous H2S. This lipophilic gas is
then eliminated by breathing (I). Due to their rapid
pharmacokinetics, these sulfur donors tend to induce
acute biological effects. On the contrary, slow HS-
releasing donors can diffuse and accumulate in other
tissues, inducing a chronic HS-mediated stimulation
with toxicity and relapse effects. However, it must
be said that low HS-releasing compounds, which
should be used at lower concentration than NaHS,
limit smelling (that can represent a serious obstacle
for a topical therapy), are easier to handle and are
generally more stable than NaHS or gaseous H2S-
enriched solutions. Several disadvantages exist
for most of the HS-releasing compounds: the
backbone of GYY4137 (36) that remains after H2S
release, the N-benzoylthiobenzamides that acylate
biological molecules carrying nucleophilic groups
and the S-diclofenac (37) have biological activities
unrelated to H2S release. A new generation of HS-
releasing compounds are synthesized (thioglycine
and I-thiovaline) with a non-toxic and inert carrier
scaffolds (38).
Several studies have
cytoprotective effects of
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concentrations, whereas exposure of cells to higher
(millimolar) HzSconcentrations tends to be cytotoxic
due to free radical generation, calcium mobilization,
glutathione depletion, and induction ofmitochondrial
cell death pathways.
Balneotherapy with naturally HzS-rich waters,
can be reproduced in part using as surrogate the
NaHS-enriched phosphate saline solution. The
concentration of HS- and Sz- in spring sulfur water
vary considerably, spanning from 0.5 to 20mg/L of
equivalent HzS. In general, spa sulfurous water for
irrigation, inhalation, bathing and drinking based-
therapies contain more than 1mg/L of HzS (11).
However, the actual type(s) and concentration(s) of
HzS donors should be determined at each source,
and the role played by temperature and additional
mineral components of spring water should also be
considered. In some studies the net effects of highly
concentrated spring water vs tap water have been
investigated, excluding that additional benefit of
balneotherapy observed in patients with psoriasis
and atopic dermatitis are due to the salinity (NaCl in
primisi of the liquids (39).
Mud, gel and other semisolid supports
have been generated and used for massage and
shampooing treatment. Clinical evaluation of the
anti-inflammatory activity of mud-pack has been
investigated and general reduction of inflammatory
cytokines (IL-6) levels have been reported (40).
CONCLUSIONS
Balneotherapy is certainly a relaxing and
restorative experience - that can be well considered
as part of the therapy - which, however, represents
a confounding element in the distinction between
"pharmacological" and placebo effects. Thus the
immediate translation into clinical studies ofthe basic
scientific findings on HzS effects cannot be made. It
is well known, in fact, that placebo effects are of
particular relevance when diseases such as psoriasis
and dermatitis are investigated. However, animal
studies might be designed for this purpose, for which
appropriate models are immediately available. The
question is whether or not there is sufficient scientific
evidence now supporting the integration of sulfur
waters in the therapy of specific skin diseases, when
appropriate (Fig. 1). Given the potential benefits
for the patients, the low-intensity caring and the
savings in health costs, this question should arise
spontaneously. However, despite the basic scientific
data on sulfurs, the belief that balneotherapy
(including sulfur water therapies) will never reach
the level of scientific demonstration of therapeutic
efficacy (40), and should therefore be kept out of
the medical field tout court, is generally diffuse. We
did not meta-analyze here the available scientific
literature in the balneotherapy field, which is, by the
way, much broader than currently believed. Instead,
we took the most active component of thermal
waters (the sulfur ion) revisiting some of its robustly
demonstrated biological effects. As a conclusion,
we believe that a special research effort could be
reasonably dedicated to bring to the same table of
discussion what is now known on the cellular effects
ofHzS and what has been observed for centuries about
the clinical effects of sulfur balneotherapy on some
dermatological conditions. No doubt prejudices of
various origines) shadow the potential link between
the two ends of this line: animal studies, we believe,
should now be implemented to close the circle.
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